Lupus Estonia

What Lupus Estonia does

Lupus Estonia is a Tallinn-based non-profit association founded in 2003 that provides support, advocacy, and education for people affected by lupus and rare rheumatic diseases in Estonia. The organisation is a national member of Lupus Europe, the Belgium-based umbrella association headquartered in Brussels (registered non-profit 0758.650.658) that coordinates 32 national lupus self-help organisations across Europe, including Lupus Estonia, representing approximately 40,000 patients in 23 full-member countries plus 7 associate-member countries. Lupus Estonia has 1-10 employees and its primary deliverables channel into Lupus Europe's broader product portfolio, which spans free multilingual digital resources, educational content, and structured engagement with European rheumatology research bodies.

The core technology platform is anchored by LupusGPT — a multilingual, AI-powered patient information chatbot built on generative AI and knowledge-retrieval techniques, validated by lupologists and patients, published in The Lancet Rheumatology in March 2026, named a finalist for the 2025 Made With Patients Awards, and refreshed with technical and security updates in April 2026. Supporting products include Lupus100 (multilingual educational platform), Lupus Clinical Trials directory, Lupus Consultation Cards, a video-on-demand library covering topics such as mitochondrial involvement in SLE, Sjogren's syndrome, cardiovascular disease, glucocorticoids, and skin manifestations, a lupus-specific exercise program endorsed by ERN and EULAR, and the LE Survey Centre hosting patient-reported research.

The business model is a non-profit donations-and-sponsorships model: Lupus Europe, the relevant funding umbrella, raised 92.3% of its 2024 funds from the pharmaceutical industry under a 20%-per-partner cap, with Hoffmann La Roche as the largest single contributor at 10.6%; remaining revenue comes from minimal membership fees from member organisations. Services are provided free of charge to patients and member organisations. Distribution is community-led via digital platforms, an annual convention, the Patient Advisory Network, and institutional partnerships including EULAR (PARE committee, shared congress exhibition), the European Reference Network ReCONNET (ePAG representative and Steering Committee), the European Patients' Forum, the DORIS+ Taskforce, the World Lupus Federation, and co-marketing with Lupus UK.

Name

Lupus Estonia

Legal name

Lupus Estonia

Website

https://lupus-europe.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Lupus Estonia is a Tallinn-based non-profit patient organisation founded in 2003 that delivers support, advocacy, and education for people affected by lupus and rare rheumatic diseases. It operates as a national member of Lupus Europe, the Brussels-headquartered umbrella coordinating 32 national patient organisations across Europe.

Ownership category

akta.pro rank

Product category

Patient Advocacy / Healthcare Non-Profit

NAICS

Other Individual and Family Services (624190), Social Assistance (624)

SIC

Services-Social Services (8300), Services-Membership Organizations (8600)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

Keywords

• Lupus patient advocacy
• Non-profit patient association
• Rare disease support
• Patient education resources
• Rheumatic disease awareness

Headquarters

HQ city

Tallinn

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Industry Funding: Primary funding source from pharmaceutical companies. In 2024, 92.3% of funds raised came from the pharmaceutical industry. Maximum 20% of funding from any single partner to maintain independence. Highest contribution from Hoffmann La Roche at 10.6% of total funds.
2. Membership Fees: Minimal membership fees and contributions collected from member organizations to maintain accessibility.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

Core offering

Lupus Estonia is a national non-profit patient organization providing support, advocacy, and education for people affected by lupus and rare rheumatic diseases in Estonia. As a national member organization of Lupus Europe, it connects Estonian lupus patients to a pan-European network of 32 national self-help organizations, multilingual patient information resources, and patient involvement in research initiatives. Services include access to validated multilingual educational platforms (LupusGPT, Lupus100), consultation cards, clinical trial information, and patient advisory networks.

Product overview

Lupus Europe operates as a patient advocacy organization offering a portfolio of digital health information tools and resources. The core offerings include LupusGPT, a multilingual AI-powered patient information tool, and Lupus100, a comprehensive educational resource. Supporting services include lupus clinical trials information, consultation cards for patient-doctor communication, educational videos on demand, an endorsed exercise program, and a survey centre for patient-reported research. These tools are free, multilingual, and validated by medical experts and patients.

Differentiator

Problem solved

Functional benefit

Products and services

• LupusGPT A multilingual AI-powered chatbot providing free, anonymous, validated lupus information to patients. Answers questions about lupus, UV light, and heat using content validated by lupologists and patients. Accessible to Lupus Estonia members as part of the umbrella network.
• Lupus100 An educational resource providing comprehensive information about lupus in multiple languages, covering topics including UV protection, symptoms, and living with the condition.
• Lupus Clinical Trials Information Service A directory and resource helping patients understand and access lupus clinical trials across Europe.
• Lupus Consultation Cards Tools designed to help patients prepare for and improve communication with their healthcare providers during consultations.
• Videos on Demand A library of educational videos featuring expert summaries on lupus-related topics including mitochondria in SLE, Sjögren's syndrome, cardiovascular disease, glucocorticoids, and skin manifestations.
• Exercise Program An exercise program developed for lupus patients that has been endorsed by ERN and EULAR.
• LE Survey Centre A portal hosting various surveys on lupus-related topics including hydroxychloroquine availability, clinical trials, COVID-19 vaccines, photosensitivity, pregnancy, and rare diseases.

Quantifiable outcome

• Living with Lupus in 2020 survey results published in Lupus, Science and Medicine journal and presented at EULAR
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• European League Against Rheumatism (EULAR)coreStrategic or Co-development PartnerLupus Europe is an active participant in EULAR PARE committee, collaborates on patient version recommendations, shares exhibition space at annual congress, and contributes to Edgar Stene Prize competition.
• European Reference Network ReCONNETcoreStrategic or Co-development PartnerLupus Europe is an ePAG (European Patient Advocacy Group) representative and Steering Committee member in ERN ReCONNET, working on rare connective tissue diseases including lupus. Collaborates on consensus definitions like ENDORSED study.
• European Patients' Forum (EPF)coreStrategic or Co-development PartnerActive participant in EPF Access to Healthcare workgroup, contributing to surveys and campaigns on patient access to healthcare at EU level.
• DORIS+ TaskforcecoreStrategic or Co-development PartnerLupus Europe participates in DORIS+ taskforce alongside clinicians and researchers working on definition of deep remission in SLE. Represented by Chair Jeanette Andersen and Board members.
• World Lupus FederationcoreStrategic or Co-development PartnerFounding member of World Lupus Federation established in 2015, uniting lupus organizations globally for coordinated awareness and advocacy efforts including World Lupus Day.
• Lupus UKminorChannel Partner/ Reseller/ DistributorShares exhibition stand with Lupus Europe at EULAR Congress, collaborating on representation at major medical conferences.
• Lupus Foundation of AmericaminorStrategic or Co-development PartnerCollaborates through World Lupus Federation on global lupus awareness initiatives and research.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Arthritis Foundation: US-based advocacy organization for arthritis and related rheumatic diseases including lupus. Comparable in patient education, research funding, and pharma partnerships within the broader rheumatology space Lupus Europe occupies through EULAR.

Broad incumbents

• National Organization for Rare Disorders (NORD): US-based umbrella for rare disease patient organizations, comparable in mission and funding mix (pharma-supported patient advocacy, education, and policy). Broader in disease scope but structurally similar to Lupus Europe at a national level.
• EURORDIS (Rare Diseases Europe): The European umbrella for rare disease patient organizations, operating at EU level with policy and research influence. Comparable as the rare-disease equivalent of Lupus Europe's lupus-specific role, with overlapping EU institutional access and patient advocacy positioning.
• European Patients' Forum (EPF): Cross-disease EU patient advocacy umbrella where Lupus Europe is an active participant (Access to Healthcare workgroup). Comparable in operating model (membership-based, pharma-funded with independence safeguards) and EU-level policy focus.

Emerging players

• American Autoimmune Related Diseases Association (AARDA): US national nonprofit focused on the cluster of autoimmune diseases including lupus. Comparable in advocacy for autoimmune patient populations, awareness campaigns, and policy engagement, with a broader disease remit.

Direct peers

• World Lupus Federation: Global federation uniting national lupus organizations worldwide, of which Lupus Europe is a founding member. Directly comparable as a coordinating body for lupus advocacy, awareness campaigns like World Lupus Day, and research engagement.
• European Federation of Crohn's & Colitis Associations (EFCCA): European umbrella of national patient organizations for Crohn's and ulcerative colitis. Comparable structurally as a Europe-wide federation of national chronic disease patient organizations with EULAR-style medical partnerships, multilingual resources, and pharma-supported funding model.
• Lupus Research Alliance: The world's largest private funder of lupus research, focused on funding science to prevent, treat, and cure lupus. Comparable in disease focus and pharma-adjacent funding model, though more research-oriented and US-centric.
• Lupus Foundation of America: The largest US-based lupus patient advocacy organization, operating as a national umbrella with research funding, education programs, and policy advocacy. Directly comparable in mission, organizational structure, and reliance on a mix of pharma, individual, and corporate funding.
• Lupus UK: The UK's national lupus patient organization and a long-standing member of Lupus Europe, sharing exhibition space at EULAR with the parent umbrella. Directly comparable as a national patient advocacy and support organization serving the same disease population.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lupus-europe

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lupus Estonia